Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Losada López IA"'
Autor:
Casasnovas C; Neuromuscular Unit, Department of Neurology, Bellvitge University Hospital-IDIBELL, C/ Feixa Llarga s/n, 08906 l'Hospitalet de Llobregat, Barcelona, Spain., Lladó L; Liver Transplant Unit, Department of Surgery, Bellvitge University Hospital, IDIBELL, Barcelona, Spain., Borrachero C; ATTRv Unit, Department of Internal Medicine, Juan Ramón Jiménez Hospital, Huelva, Spain., Pérez-Santamaría PV; Department of Internal Medicine of Neurology, Bellvitge University Hospital, Barcelona, Spain., Muñoz-Beamud F; Department of Internal Medicine, Juan Ramón Jiménez Hospital, Huelva, Spain., Losada-López IA; ATTRv Unit, Department of Internal Medicine, Son Llàtzer University Hospital, Palma de Mallorca, Spain., Baliellas-Comellas MC; Department of Surgery, Bellvitge University Hospital, IDIBELL, Barcelona, Spain., González-Moreno J; Department of Internal Medicine, Son Llàtzer University Hospital, Palma de Mallorca, Spain.
Publikováno v:
Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2023 Aug 24; Vol. 16, pp. 17562864231191590. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).
Autor:
Losada-López IA; Internal Medicine Service, Hospital Universitario Son Llátzer, Palma, Spain; Balearic Research Group in Genetic Cardiopathies, Sudden Death and TTR Amyloidosis, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma, Spain. Electronic address: ialosada@hsll.es., Kapetanovic-García S; Unidad de ELA y neuromuscular, Hospital Universitario Basurto, Bilbao, Spain., Sevilla-Mantecón T; Hospital Universitari i Politècnic La Fe & IIS La Fe, Neuromuscular Diseases Unit, Department of Neurology, Valencia, Spain; Universitat de València, Valencia, Spain; Biomedical Research Network Center in Rare Diseases (CIBERER); Member of the European Reference Network for Rare Neuromuscular Diseases (ERN EURO-NMD), Spain., Muñoz-Beamud F; Facultativo Especialista de Área de Medicina Interna, Unidad de Enfermedades Autoinmunes, Minoritarias y Trombosis, Coordinador Unidad Multidisciplinar de Amiloidosis Hereditaria, Servicio de Medicina Interna, Hospital Juan Ramón Jiménez, Spain.
Publikováno v:
Medicina clinica [Med Clin (Barc)] 2023 Mar 10; Vol. 160 (5), pp. 213-217. Date of Electronic Publication: 2022 Dec 16.
Autor:
Adams D; Université Paris-Saclay, U1195, INSERM, Le Kremlin Bicêtre, France; Neurology Department, AP-HP, Centre Hospitalier Universitaire Bicêtre, Le Kremlin Bicêtre, France. Electronic address: david.adams@aphp.fr., Polydefkis M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., González-Duarte A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Wixner J; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Kristen AV; Department of Cardiology, University of Heidelberg, Heidelberg, Germany., Schmidt HH; University of Münster, Münster, Germany., Berk JL; Boston Medical Center, Boston, MA, USA., Losada López IA; Balearic Islands Health Research Institute, Palma, Spain., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Quan D; University of Colorado, Denver, CO, USA., Conceição IM; Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria and Faculdade de Medicina, Lisbon, Portugal., Slama MS; Cardiology Department, Centre de Compétence Amylose Cardiaque, Centre Hospitalier Universitaire Xavier Bichat Assistance Publique Hôpitaux de Paris, Université Paris-Saclay, Paris, France., Gillmore JD; National Amyloidosis Centre, University College London, Royal Free Hospital, London, UK., Kyriakides T; The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; Medical School, University of Nicosia, Nicosia, Cyprus., Ajroud-Driss S; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Waddington-Cruz M; Hospital Universitario Clementino Fraga Filho-Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Mezei MM; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Planté-Bordeneuve V; Centre Hospitalier Universitaire, Henri Mondor-Assistance Publique Hopitaux de Paris, Univ Paris Est Creteil, INSERM, IMRB, Creteil, France., Attarian S; Neuromuscular disorders and ALS Department, Centre Hospitalier Universitaire La Timone, Marseille, France., Mauricio E; Mayo Clinic, Jacksonville, FL, USA., Brannagan TH 3rd; Columbia University, College of Physicians and Surgeons, Neurology Department, New York, NY, USA., Ueda M; Kumamoto University Hospital, Department of Neurology, Kumamoto, Japan., Aldinc E; Alnylam Pharmaceuticals, Cambridge, MA, USA., Wang JJ; Alnylam Pharmaceuticals, Cambridge, MA, USA., White MT; Alnylam Pharmaceuticals, Cambridge, MA, USA., Vest J; Alnylam Pharmaceuticals, Cambridge, MA, USA., Berber E; Alnylam Pharmaceuticals, Cambridge, MA, USA; Myokardia, Brisbane, CA, USA., Sweetser MT; Alnylam Pharmaceuticals, Cambridge, MA, USA., Coelho T; Centro Hospitalar Universitário do Porto, Porto, Portugal.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2021 Jan; Vol. 20 (1), pp. 49-59. Date of Electronic Publication: 2020 Nov 16.